Trevi Therapeutics (TRVI) PT Lowered to $23 at Needham
Needham analyst Serge Belanger lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)